Logo image of INNV

INNOVAGE HOLDING CORP (INNV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:INNV - US45784A1043 - Common Stock

5.88 USD
+0.33 (+5.95%)
Last: 12/17/2025, 8:00:02 PM
5.88 USD
0 (0%)
After Hours: 12/17/2025, 8:00:02 PM
Fundamental Rating

4

Taking everything into account, INNV scores 4 out of 10 in our fundamental rating. INNV was compared to 100 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for INNV as it has an excellent financial health rating, but there are worries on the profitability. INNV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

INNV had negative earnings in the past year.
INNV had a positive operating cash flow in the past year.
In the past 5 years INNV always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: INNV reported negative operating cash flow in multiple years.
INNV Yearly Net Income VS EBIT VS OCF VS FCFINNV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

1.2 Ratios

INNV has a Return On Assets of -3.40%. This is in the lower half of the industry: INNV underperforms 63.00% of its industry peers.
INNV has a Return On Equity (-7.09%) which is in line with its industry peers.
Industry RankSector Rank
ROA -3.4%
ROE -7.09%
ROIC N/A
ROA(3y)-5.61%
ROA(5y)-5.25%
ROE(3y)-11.52%
ROE(5y)-9.93%
ROIC(3y)N/A
ROIC(5y)N/A
INNV Yearly ROA, ROE, ROICINNV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

INNV's Gross Margin of 19.27% is on the low side compared to the rest of the industry. INNV is outperformed by 61.00% of its industry peers.
In the last couple of years the Gross Margin of INNV has declined.
The Profit Margin and Operating Margin are not available for INNV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.44%
GM growth 5Y-6.3%
INNV Yearly Profit, Operating, Gross MarginsINNV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20

7

2. Health

2.1 Basic Checks

INNV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INNV has been reduced compared to 1 year ago.
Compared to 5 years ago, INNV has more shares outstanding
Compared to 1 year ago, INNV has an improved debt to assets ratio.
INNV Yearly Shares OutstandingINNV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
INNV Yearly Total Debt VS Total AssetsINNV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.32 indicates that INNV is not in any danger for bankruptcy at the moment.
INNV has a better Altman-Z score (3.32) than 70.00% of its industry peers.
The Debt to FCF ratio of INNV is 1.95, which is an excellent value as it means it would take INNV, only 1.95 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of INNV (1.95) is better than 84.00% of its industry peers.
INNV has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of INNV (0.25) is better than 69.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 1.95
Altman-Z 3.32
ROIC/WACCN/A
WACC8.67%
INNV Yearly LT Debt VS Equity VS FCFINNV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

INNV has a Current Ratio of 1.17. This is a normal value and indicates that INNV is financially healthy and should not expect problems in meeting its short term obligations.
INNV has a Current ratio (1.17) which is comparable to the rest of the industry.
INNV has a Quick Ratio of 1.17. This is a normal value and indicates that INNV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.17, INNV is in line with its industry, outperforming 46.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
INNV Yearly Current Assets VS Current LiabilitesINNV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

INNV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.00%, which is quite impressive.
Looking at the last year, INNV shows a quite strong growth in Revenue. The Revenue has grown by 12.48% in the last year.
INNV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.52% yearly.
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)12.48%
Revenue growth 3Y6.91%
Revenue growth 5Y8.52%
Sales Q2Q%15.09%

3.2 Future

INNV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 77.26% yearly.
Based on estimates for the next years, INNV will show a quite strong growth in Revenue. The Revenue will grow by 9.21% on average per year.
EPS Next Y243.44%
EPS Next 2Y100.2%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue Next Year9.21%
Revenue Next 2Y9.39%
Revenue Next 3Y9.21%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
INNV Yearly Revenue VS EstimatesINNV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INNV Yearly EPS VS EstimatesINNV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -5 -10 -15

4

4. Valuation

4.1 Price/Earnings Ratio

INNV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 18.30, which indicates a rather expensive current valuation of INNV.
Based on the Price/Forward Earnings ratio, INNV is valued a bit cheaper than 65.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.58. INNV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 18.3
INNV Price Earnings VS Forward Price EarningsINNV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INNV is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, INNV is valued a bit cheaper than the industry average as 63.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.11
EV/EBITDA 43.89
INNV Per share dataINNV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

INNV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as INNV's earnings are expected to grow with 77.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y100.2%
EPS Next 3Y77.26%

0

5. Dividend

5.1 Amount

No dividends for INNV!.
Industry RankSector Rank
Dividend Yield 0%

INNOVAGE HOLDING CORP

NASDAQ:INNV (12/17/2025, 8:00:02 PM)

After market: 5.88 0 (0%)

5.88

+0.33 (+5.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-02 2026-02-02
Inst Owners12.13%
Inst Owner Change-0.6%
Ins Owners0.9%
Ins Owner Change0.34%
Market Cap797.80M
Revenue(TTM)884.66M
Net Income(TTM)-17.36M
Analysts45
Price Target6.12 (4.08%)
Short Float %1.37%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)273.11%
Min EPS beat(2)57.98%
Max EPS beat(2)488.24%
EPS beat(4)2
Avg EPS beat(4)-68.35%
Min EPS beat(4)-527.45%
Max EPS beat(4)488.24%
EPS beat(8)4
Avg EPS beat(8)-20.2%
EPS beat(12)5
Avg EPS beat(12)-33.17%
EPS beat(16)5
Avg EPS beat(16)-65.91%
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)2.15%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)2.15%
Revenue beat(8)4
Avg Revenue beat(8)0.06%
Revenue beat(12)5
Avg Revenue beat(12)-0.53%
Revenue beat(16)6
Avg Revenue beat(16)-0.63%
PT rev (1m)0%
PT rev (3m)2.86%
EPS NQ rev (1m)33.33%
EPS NQ rev (3m)166.67%
EPS NY rev (1m)50%
EPS NY rev (3m)350%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.3
P/S 0.9
P/FCF 22.11
P/OCF 18.04
P/B 3.26
P/tB 8.04
EV/EBITDA 43.89
EPS(TTM)-0.06
EYN/A
EPS(NY)0.32
Fwd EY5.46%
FCF(TTM)0.27
FCFY4.52%
OCF(TTM)0.33
OCFY5.54%
SpS6.52
BVpS1.81
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.4%
ROE -7.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.27%
FCFM 4.08%
ROA(3y)-5.61%
ROA(5y)-5.25%
ROE(3y)-11.52%
ROE(5y)-9.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.44%
GM growth 5Y-6.3%
F-Score6
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 1.95
Debt/EBITDA 3.83
Cap/Depr 42.43%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion 270.83%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 3.32
F-Score6
WACC8.67%
ROIC/WACCN/A
Cap/Depr(3y)75.1%
Cap/Depr(5y)131.8%
Cap/Sales(3y)1.72%
Cap/Sales(5y)2.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y243.44%
EPS Next 2Y100.2%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue 1Y (TTM)12.48%
Revenue growth 3Y6.91%
Revenue growth 5Y8.52%
Sales Q2Q%15.09%
Revenue Next Year9.21%
Revenue Next 2Y9.39%
Revenue Next 3Y9.21%
Revenue Next 5YN/A
EBIT growth 1Y83.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year300.05%
EBIT Next 3Y71.49%
EBIT Next 5YN/A
FCF growth 1Y181.77%
FCF growth 3YN/A
FCF growth 5Y-3.62%
OCF growth 1Y270.88%
OCF growth 3Y6.38%
OCF growth 5Y-5.59%

INNOVAGE HOLDING CORP / INNV FAQ

Can you provide the ChartMill fundamental rating for INNOVAGE HOLDING CORP?

ChartMill assigns a fundamental rating of 4 / 10 to INNV.


Can you provide the valuation status for INNOVAGE HOLDING CORP?

ChartMill assigns a valuation rating of 4 / 10 to INNOVAGE HOLDING CORP (INNV). This can be considered as Fairly Valued.


What is the profitability of INNV stock?

INNOVAGE HOLDING CORP (INNV) has a profitability rating of 1 / 10.